FDA Grants Orphan Drug Designation to Cellectar’s CLR 131 for the Sixth Time

  The biopharmaceutical company Cellectar Biosciences recently announced that the FDA granted its lead phospholipid drug conjugate, CLR 131, Orphan Drug Designation(ODD) for treatment of lymphoplasmacytic lymphoma. ODD is granted by…

Continue Reading FDA Grants Orphan Drug Designation to Cellectar’s CLR 131 for the Sixth Time
Bayer’s Aliqopa Receives Breakthrough Therapy Status for Marginal Zone Lymphoma
source: pixabay.com

Bayer’s Aliqopa Receives Breakthrough Therapy Status for Marginal Zone Lymphoma

According to a publication from Benzinga, the U.S. Food and Drug Administration has granted Breakthrough Therapy status to Bayer's relapsed follicular lymphoma drug Aliqopa (copanlisib) for the treatment of marginal…

Continue Reading Bayer’s Aliqopa Receives Breakthrough Therapy Status for Marginal Zone Lymphoma
Possible Treatment for Marginal Zone Lymphoma Earns Orphan Drug Designation
GDJ / Pixabay

Possible Treatment for Marginal Zone Lymphoma Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company TG Therapeutics, Inc. recently made an announcement declaring that the US Food and Drug Administration (FDA) had awarded the company Orphan…

Continue Reading Possible Treatment for Marginal Zone Lymphoma Earns Orphan Drug Designation

Updates From Celgene in Follicular Lymphoma, Marginal Zone Lymphoma, Beta Thalassemia, and other Rare Diseases

Celgene Corporation has recently announced two exciting updates for the rare disease community! Update #1 The first big announcement from Celgene was that their supplemental New Drug Application (sNDA) for…

Continue Reading Updates From Celgene in Follicular Lymphoma, Marginal Zone Lymphoma, Beta Thalassemia, and other Rare Diseases
Marginal Zone Lymphoma Isn’t Stopping This Professor From Showing His School Spirit
Morac / Pixabay

Marginal Zone Lymphoma Isn’t Stopping This Professor From Showing His School Spirit

According to a story from wect.com, Dr. Jorge Figueroa, who has been a teaching for nine years at the University of North Carolina at Wilmington, has developed a reputation as…

Continue Reading Marginal Zone Lymphoma Isn’t Stopping This Professor From Showing His School Spirit
Huge Childhood Cancer Study Now Underway
Source: pixabay.com

Huge Childhood Cancer Study Now Underway

The Children’s Oncology Group (COG) and the National Cancer Institute (NCI) and have begun collaborating on a new project, to be known as the Pediatric Molecular Analysis for Therapy Choice…

Continue Reading Huge Childhood Cancer Study Now Underway
Look No Further: We Have All the Latest in the Marginal Zone Lymphoma Community
Source: pixabay.com

Look No Further: We Have All the Latest in the Marginal Zone Lymphoma Community

There’s a lot that the marginal zone lymphoma community needs, but there is also a lot being said. Results from clinical trials are coming in, and patient testimonials are shedding…

Continue Reading Look No Further: We Have All the Latest in the Marginal Zone Lymphoma Community
Close Menu